Concepedia

Reconstitution Time

Reconstitution Time is a pharmaceutical metric that denotes the duration required for a sterile lyophilized formulation to fully dissolve and return to its original liquid state under specified conditions, distinguishing it from other reconstitution parameters by quantifying the temporal aspect of solubilization.

26

Publications

1.1K

Citations

108

Authors

48

Institutions

Publications per year

2017–2026

15

Variants

Reconstitution Duration

Parents

Publications

26

Intermediate-Term Hematopoietic Stem Cells with Extended but Time-Limited Reconstitution Potential

Patricia Benveniste, Catherine Frelin, Salima Janmohamed et al. · Cell stem cell · 2010 · 194 citations · Full text

, , +14

Long term lymphocyte reconstitution after alemtuzumab treatment of multiple sclerosis

Grant Hill-Cawthorne, Tom Button, Orla Tuohy et al. · Journal of Neurology Neurosurgery & Psychiatry · 2011 · 194 citations

, , +17

Early reconstitution of effector memory CD4+ CMV-specific T cells protects against CMV reactivation following allogeneic SCT

Batoul Pourgheysari, Andrew McLarnon, Julie Arrazi et al. · Bone Marrow Transplantation · 2008 · 78 citations

, , +16

On the Reconstitution Problem in the Multiple Time-Scale Method

Angelo Luongo, Achille Paolone · Nonlinear Dynamics · 1999 · 58 citations

, , +8

Insights into the influence of the cooling profile on the reconstitution times of amorphous lyophilized protein formulations

Karen E. Beech, James G. Biddlecombe, Christopher F. van der Walle et al. · European Journal of Pharmaceutics and Biopharmaceutics · 2015 · 56 citations · Full text

, , +17

1–5 of 26

Authors

108

  1. RH
    Robin H. Bogner

    University of Connecticut, United States

    3 publications · 86 citations

    3

    h-index

  2. SS
    Shreya S. Kulkarni

    University of Connecticut, United States

    3 publications · 86 citations

    3

    h-index

  3. SM
    Sajal M. Patel

    University of Connecticut, United States

    2 publications · 36 citations

    2

    h-index

  4. JV
    Joseph V. Rinella

    GlaxoSmithKline (United States), United States

    2 publications · 63 citations

    2

    h-index

  5. JH
    Jörg Huwyler

    University of Basel, Switzerland

    2 publications · 52 citations

    2

    h-index

1–5 of 108

Institutions

48

  1. University of Connecticut

    Storrs, United States

    3 h-index

    6 publications

    172 citations

  2. University of Basel

    Basel, Switzerland

    2 h-index

    4 publications

    104 citations

  3. GlaxoSmithKline (United States)

    Philadelphia, United States

    2 h-index

    2 publications

    63 citations

  4. AstraZeneca (United States)

    Wilmington, United States

    2 h-index

    2 publications

    36 citations

  5. University of Minnesota

    Minneapolis, United States

    2 h-index

    2 publications

    63 citations

  6. Roche (Switzerland)

    Basel, Switzerland

    2 h-index

    6 publications

    156 citations

  7. Heidelberg University

    Heidelberg, Germany

    1 h-index

    2 publications

    22 citations

  8. King Abdullah University of Science and Technology

    Jeddah, Saudi Arabia

    1 h-index

    1 publications

    194 citations

1–8 of 48

Venues

  1. European Journal of Pharmaceutics and Biopharmaceutics

    EJPB · 4 publications · 161 citations

    4

    h-index

  2. Journal of Pharmaceutical Sciences

    3 publications · 47 citations

    4

    h-index

  3. American Journal of Hematology

    AJH · 1 publications · 46 citations

    1

    h-index

  4. Haematologica

    1 publications · 19 citations

    1

    h-index

  5. 1

    h-index

1–5